The aim of this study was to examine the suitability of [
| I N TR ODU C TI ON
Neuronal-type nicotinic acetylcholine receptors (nAChRs) are made of five subunits in homomeric or heteromeric combinations of a2-a10 and b2-b4 subunits (Gotti & Clementi, 2004) . Heteromeric combinations of the a4 or b2 subunits (e.g., a4 3 b2 2 or a4 2 b2 3 ) represent the most abundant neuronal-type nAChR in the mammalian brain (Lindstrom et al., 1995) , and any combination of the two are collectively referred to as a4b2* nAChRs. The a4b2* nAChR is a ligand-gated ion channel that is nonselectively permeable to Na 1 and K
1
, which can cause membrane depolarization leading to presynaptic and postsynaptic excitation. The a4b2* nAChR system is involved in memory, attention, and mood, as well as the regulation of other neurotransmitters (Gotti & Clementi, 2004) . The expression of a4b2* nAChRs could provide clinically useful information about abnormalities in neurodevelopment (e.g., changes due to fetal alcohol exposure), substance abuse (e.g., tobacco and alcohol addiction), and neurological disease and disorders (e.g., Alzheimer's disease, Parkinson's disease, epilepsy, or schizophrenia), as well as healthy aging (Gotti & Clementi, 2004; Hillmer et al., 2014) .
The clinical and scientific relevance of a4b2* nAChRs demonstrates a need for a positron emission tomography (PET) radioligand for these receptors, particularly an agonist, which may be more sensitive to competing endogenous ligands than an antagonist. The first a4b2* nAChR agonist radioligand was [ 11 C]nicotine; however, the high nonspecific binding and rapid dissociation precluded its use in PET studies (Nybäck, Halldin, Åhlin, Curvall, & Eriksson, 1994) . A high-affinity radio- (Pichika et al., 2006) . Nifene exhibited subnanomolar affinities for the cloned human a2b2 (0.34 nM), a3b2 (0.80 nM), and a4b2 (0.83 nM) subtypes in rats and was found to be significantly weaker for other human nAChR subtypes (Liang, Patel, Pan, & Mukherjee, 2016 well as a binding profile similar to the known brain distribution of a4b2* nAChRs in mice, rats, and non-human primates (Constantinescu et al., 2013; Hillmer, Wooten, Farhoud, et al., 2013; Hillmer et al., 2012; Pichika et al., 2006 (Constantinescu et al., 2013 Ga rotating rod sources), eight subjects underwent dynamic [ 
| Data analysis
PET data were realigned frame-by-frame to correct for motion (SPM12), and then HYPR-LR was implemented for time-activity curve (TAC) denoising (6 mm; MATLAB2015a) (Floberg et al., 2012) . The T1
MRI and FreeSurfer anatomical ROI segmentation were then coregistered to the PET data. Parametric DVR images were generated using MRTM2 (MATLAB2015a), which allows for the estimation of DVR given a reference region with negligible specific binding (corpus callosum FreeSurfer ROI; volume 5 3.06 6 0.55 cm First, k 2 0 was estimated voxel-wise from the 3-parameter multilinear reference tissue method (MRTM), given by (Ichise et al., 2003) :
where C(T) is the voxel activity concentration, k 2 is the tracer clearance rate from tissue, and R 1 is the relative tracer deliver (K 1 /K 1 0 ). The prime sign indicates the parameters for the reference region. The median k 2 0 from each scan was used (coefficient of variation: 16%) over the ROIbased estimation (19%) . Other studies have also demonstrated the same level of variability between voxel-based and ROI-based k 2 0 estimation (Wu & Carson, 2002) . The k 2 0 estimates were tested for significant differences between test and retest with a related samples
Wilcoxon signed rank tests (IBM SPSS Statistics 21). Then, the median k 2 0 was used as an input to MRMT2, given by (Ichise et al., 2003) :
DVR can then be calculated as R 1 k 2 0 /k 2 . MRTM2 DVR estimation was also performed using an a priori k 2 0 of 0.20 min 21 based on a 1-tissue compartmental model with an arterial input function performed in rhesus monkey (Hillmer, Wooten, Slesarev, et al., 2013) to evaluate the use of a population k 2 0 parameter.
The T1 MRI and FreeSurfer defined ROIs were also coregistered to the retest PET data (realigned by frame), and DVR estimation was similarly performed in PET space. Mean DVR values were extracted from parametric DVR images for the thalamus (14.1 6 1.8 cm 
| Reproducibility analysis
Test-retest reproducibility was evaluated by calculating the test-retest variability (TRV), absolute test-retest variability (aTRV), and intraclass correlation coefficient (ICC). The TRV was calculated as the difference between the test and retest DVRs as a percentage of the average of the test and retest DVRs, according to (Hammers et al., 2007) :
The aTRV was calculated as the absolute value of the TRV. The ICC, which is an estimate of the reliability of the two sets of DVR measurements within the same subject, varies from 21 (no reliability) to 1 (total reliability, i.e., identical test and retest), and commonly interpreted as poor (ICC < 0.4), fair (0.4 < ICC < 0.75), or excellent (ICC > 0.75) (British Standards Institution, 1994) . ICC was calculated using a one-way effects model as:
where MSBS is the mean sum of squares between subjects, MSWS is the mean sum of squares within subjects, and k is the number of within subject measurements (in the test-retest paradigm, k 5 2) (Shrout & Fleiss, 1979) . The TRV and aTRV are reported as mean 6 standard deviation, while the ICC is reported with its associated 95% confidence interval. TRV and aTRV were each tested against the null hypothesis of no variability with a 1-sample Wilcoxon signed rank test (IBM SPSS Statistics 21).
| R ESU L TS
There were no adverse effects (i.e., changes in vital signs or relevant laboratory tests) that were attributable to the administration of radiotracer in any of the eight subjects. TACs, expressed as standard uptake value across subjects, are shown in Figure 1 for representative regions.
The highest uptake was observed in the thalamus, which peaked prior to 10 min postinjection. The lateral geniculate nucleus and the substantia nigra/ventral tegmental area demonstrated similar kinetics as the thalamus. Cortical and subcortical regions showed rapid uptake, peaking at approximately 5 min. The corpus callosum showed markedly lower uptake than other regions. All regions demonstrated fast clearance. Target to corpus callosum ratios are shown in Figure 2 , where ratios range from 1 to 2.5 and temporal stability occurs after 20 min.
The estimated k 2 0 values using MRTM are summarized in Table 1 .
There was no significant difference between test and retest k 2 0 (p 5 0.30). The k 2 0 TRV (11 6 23%) was moderately positive, but was not significantly different from zero (p 5 0.24). An a priori k 2 0 (as opposed to a test k 2 0 and a retest k 2 0 ) was investigated to determine its influence on the DVR test-retest variability. The percent difference in the estimated k 2 0 parameters from the a priori k 2 0 was 29 6 12%. Voxelwise comparison between the parametric DVR images generated from The test-retest DVR reproducibility metrics are summarized in Table 2 . The magnitude of the deviation between test and retest (aTRV) was significantly different from zero in all ROIs. However, the TRV was not significantly different from zero in any ROI. The ICC was high in the cerebellum, temporal and parietal cortices, and striatum, moderate in the frontal and rostral cortices, hippocampus, anterior cingulate, and low in the thalamus.
Temporal stability of DVR estimates was investigated by truncating dynamic data at 10 min intervals and comparing to the full 90 min derived estimates. Figure 4 demonstrates minimal change in DVR estimation when scan duration is truncated. The percent difference for 30, 40, 50, 60, 70, and 80 min datasets compared to the full 90 min dataset is 5.6 6 3.2%, 3.6 6 2.6%, 2.4 6 1.7%, 1.6 6 1.1%, 1.0 6 0.6%, and 0.4 6 0.3%, respectively, for the highest binding region (thalamus). For comparison, a low binding region (frontal cortex) has respective percent differences of 4.9 6 2.0%, 2.8 6 1.6%, 1.5 6 1.3%, 0.9 6 1.0%, 0.5 6 0.7%, 0.2 6 0.5%. Dataset truncation did not significantly affect the ICCs (p > .05).
| D I SCUSSION
This study reports the first-in-human evaluation of [ (Brody et al., 2006; Kimes et al., 2003) . MRTM2 DVR estimation demonstrated test-retest variability comparable to most PET radioligands, with a magnitude ranging from 6 to 11% with no systematic difference between test and retest, for these studies with injected doses of 200 6 3.7 MBq. Whole-body dosimetry studies are ongoing and will likely yield a higher allowable injected dose and improved imaging statistics.
The region of highest [
18 F]nifene DVR was the thalamus, which was also the region of lowest ICC. The ICC uses information about the systematic difference between methods within a subject (i.e., test and retest) and information about the random measurement variation between subjects. The magnitude of the DVR value does not influence the value of the ICC. The ICC equation shows that for a given withinsubject variability a higher between-subject variability will lead to a higher ICC. For instance, the hippocampus and the temporal cortex have a similar within-subject variabilityof 7%, but the hippocampus has a between-subject variability of 9% and the temporal cortex has a between-subject variability of 12%, which lead to ICCs of 0.66 and 0.83, respectively. However, in the thalamus, the within-subject variability is 11% and the between-subject variability is 9%, leading to a low ICC of 0.26 in this small sample size.
Scan duration is an important factor in the translation of a novel radiotracer for use in human research. The scan needs to be long enough to obtain stable estimate of parameters related to receptor density as well as to provide sufficient counting statistics, however, it is also desirable to shorten the scan duration to minimize the potential discomfort for subjects lying motionless for an extended period of time. For imaging the a4b2* nAChRs, the commonly used [ studies in rhesus monkeys showed that MRTM2 estimations were similar to those from a 1-tissue kinetic analysis when using an arterial input function (Hillmer, Wooten, Slesarev, et al., 2013) . The corpus callosum was selected as a reference region based on previous human imaging studies of a4b2* nAChRs (Brody et al., 2006) , which reported displaceable binding in the cerebellum but not in the corpus callosum following cigarette smoking. The corpus callosum has also been used as a reference region in human a4b2* PET studies of Parkinson's disease (Meyer et al., 2009 
